Litcius/Paper detail

ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial

Maria Petracca, Mario Quarantelli, Marcello Moccia, Giovanni Vacca, Barbara Satelliti, Gianluigi D'Ambrosio, Antonio Carotenuto, Monica Ragucci, Francesco Assogna, Antonio Capacchione, Roberta Lanzillo, Vincenzo Brescia Morra

2021Multiple Sclerosis and Related Disorders49 citationsDOI

Topics & Concepts

TolerabilityMedicineCurcuminMultiple sclerosisPlaceboInternal medicineClinical endpointGastroenterologyClinical trialAdverse effectPharmacologyPathologyImmunologyAlternative medicineCurcumin's Biomedical ApplicationsMultiple Sclerosis Research StudiesMicroRNA in disease regulation